FDA wants yet more data on Takeda diabetes drug alogliptin

Article Date: 26/04/2012 10:00
FDA wants yet more data on Takeda diabetes drug alogliptin

Vacancy Search

Quick job search

Advanced Search

Latest News

FDA to review Pfizer's once-daily Xeljanz for RA

FDA to review Pfizer's once-daily Xeljanz for RA

Sanofi's Lantus, Gilead's Harvoni welcomed to Japan

Sanofi's Lantus, Gilead's Harvoni welcomed to Japan

FDA approves new cystic fibrosis drug Orkambi

FDA approves new cystic fibrosis drug Orkambi

ViiV set to offer cheap HIV drugs in China

ViiV set to offer cheap HIV drugs in China

Sector’s smaller players show the way

With the Nasdaq biotech index proving remarkably resilient to sector-specific and macroeconomic problems alike, smart investors will continue to keep an eye out for signs of panic as a...

UK leads EU in antibiotic diagnostics research

UK leads EU in antibiotic diagnostics research

Pfizer teams up with NIHR

Pfizer teams up with NIHR

Boehringer COPD combination approved in Europe

Boehringer COPD combination approved in Europe

Opdivo launches in UK

Opdivo launches in UK

Medtech floats remain steady in 2015

The striking thing about the half-year figures for IPOs in the medtech sphere is the similarity they bear to those for the previous six-month period. The 14 device companies that have...
more news